Ventyx Biosciences Announces Positive Results from the Phase

Ventyx Biosciences Announces Positive Results from the Phase 2 Trial of VTX002 in Patients with Moderate-to-Severely Active Ulcerative Colitis

Ventyx Biosciences Announces Positive Results from the Phase 2 Trial of VTX002 in Patients with Moderate-to-Severely Active Ulcerative Colitis

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

San Diego , California , United States , Ukraine , Raju Mohan , Ventyx Biosciences , Pbruce Sands , Burrillb Crohn , William Sandborn , Ventyx Biosciences Inc , Nasdaq , Exchange Commission , Icahn School Of Medicine At Mount Sinai , Patti Bank , Chief Executive , Mayo Clinic , Chief Medical , Mount Sinai , Icahn School , Risk Factors , Quarterly Report , Private Securities Litigation Reform Act ,